IndraLab

Statements


ALYREF binds USP3 and MYCN. 1 / 1
| 1

reach
"The ALYREF-USP3-MYCN complex is a potential therapeutic target for NB by exploiting obligatory ALYREF dependence in MYCN-amplified cells [37]."